Published in Pharm World Sci on April 01, 1998
Reimbursement restriction and moderate decrease in benzodiazepine use in general practice. Ann Fam Med (2012) 1.04
Benzodiazepine prescribing behaviour and attitudes: a survey among general practitioners practicing in northern Thailand. BMC Fam Pract (2005) 0.97
Correlates of (inappropriate) benzodiazepine use: the Netherlands Study of Depression and Anxiety (NESDA). Br J Clin Pharmacol (2011) 0.96
Utilization of hypnotic medication in the context of cancer: predictors and frequency of use. Support Care Cancer (2011) 0.91
The impact of hospitalisation on the initiation and long-term use of benzodiazepines. Eur J Clin Pharmacol (2005) 0.90
Benzodiazepine use in the real world of psychiatric practice: low-dose, long-term drug taking and low rates of treatment discontinuation. Eur J Clin Pharmacol (2007) 0.88
Prevalence and correlates of psychotropic medication use among older adults in Israel: cross-sectional and longitudinal findings from two cohorts a decade apart. Aging Ment Health (2012) 0.81
Prescribing antidepressants and benzodiazepines in the Netherlands: is chronic physical illness involved? Depress Res Treat (2010) 0.80
Differences in health status between long-term and short-term benzodiazepine users. Br J Gen Pract (2002) 0.80
Initial 3-month usage characteristics predict long-term use of benzodiazepines: an 8-year follow-up. Eur J Clin Pharmacol (2003) 0.77
Effects of legal and illegal use of benzodiazepines at acute admission to a psychiatric acute department. BMC Res Notes (2010) 0.75
Epidemiology of fractures in England and Wales. Bone (2001) 5.76
Hypoglycaemia associated with use of inhibitors of angiotensin converting enzyme. Lancet (1995) 5.02
Use of oral corticosteroids and risk of fractures. J Bone Miner Res (2000) 4.75
Venous thromboembolism among new users of different oral contraceptives. Lancet (1999) 3.25
Impact of dosage frequency on patient compliance. Diabetes Care (1997) 2.43
Antihypertensive drug therapies and the risk of ischemic stroke. Arch Intern Med (2001) 2.24
A region of the Herpesvirus saimiri genome required for oncogenicity. Science (1985) 2.22
Risk of extrapyramidal syndromes with haloperidol, risperidone, or olanzapine. Ann Pharmacother (2001) 2.14
Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology (Oxford) (2000) 2.13
Benzodiazepines and the risk of falling leading to femur fractures. Dosage more important than elimination half-life. Arch Intern Med (1995) 2.13
Use of oral corticosteroids in the United Kingdom. QJM (2000) 1.95
Construction of replication-competent Herpesvirus saimiri deletion mutants. J Virol (1984) 1.89
Pharmaco-morbidity linkage: a feasibility study comparing morbidity in two pharmacy based exposure cohorts. J Epidemiol Community Health (1992) 1.81
An IL-13 promoter polymorphism associated with increased risk of allergic asthma. Genes Immun (1999) 1.75
The use of a large pharmacoepidemiological database to study exposure to oral corticosteroids and risk of fractures: validation of study population and results. Pharmacoepidemiol Drug Saf (2000) 1.70
Conditional identification of phosphate-starvation-response mutants in Arabidopsis thaliana. Planta (2000) 1.68
Absence of jaagsiekte sheep retrovirus DNA and RNA in bronchioloalveolar and conventional human pulmonary adenocarcinoma by PCR and RT-PCR analysis. Hum Pathol (2001) 1.66
Sex differences in the pharmacological treatment of hypertension: a review of population-based studies. J Hypertens (1997) 1.62
Tissue distribution of human minor histocompatibility antigens. Ubiquitous versus restricted tissue distribution indicates heterogeneity among human cytotoxic T lymphocyte-defined non-MHC antigens. J Immunol (1992) 1.55
Women with angina pectoris receive less antiplatelet treatment than men. Br J Gen Pract (1999) 1.51
Use of sympathomimetic drugs leads to increased risk of hospitalization for arrhythmias in patients with congestive heart failure. Arch Intern Med (2000) 1.50
Peptides which bind to E-selectin and block neutrophil adhesion. J Biol Chem (1995) 1.48
A gene for dihydrofolate reductase in a herpesvirus. Science (1988) 1.47
Signalling possible drug-drug interactions in a spontaneous reporting system: delay of withdrawal bleeding during concomitant use of oral contraceptives and itraconazole. Br J Clin Pharmacol (1999) 1.46
Non-puerperal lactation associated with antidepressant drug use. Br J Clin Pharmacol (1997) 1.46
Channeling of three newly introduced antidepressants to patients not responding satisfactorily to previous treatment. J Clin Psychopharmacol (1997) 1.42
Association between oxybutynin and neuropsychiatric adverse effects not confirmed in daily practice. J Am Geriatr Soc (2001) 1.39
Detecting drug-drug interactions using a database for spontaneous adverse drug reactions: an example with diuretics and non-steroidal anti-inflammatory drugs. Eur J Clin Pharmacol (2000) 1.37
Characterization of two classes of ribonucleoprotein complexes possibly involved in RNA editing from Leishmania tarentolae mitochondria. EMBO J (1994) 1.36
Tendon disorders attributed to fluoroquinolones: a study on 42 spontaneous reports in the period 1988 to 1998. Arthritis Rheum (2001) 1.35
Covalent dimerization of vascular permeability factor/vascular endothelial growth factor is essential for its biological activity. Evidence from Cys to Ser mutations. J Biol Chem (1994) 1.33
Induction of insulin resistance by androgens and estrogens. J Clin Endocrinol Metab (1994) 1.28
The origin and molecular characterization of adenoid basal carcinoma of the uterine cervix. Int J Gynecol Pathol (1997) 1.24
Cardiovascular diseases and risk factors in a population-based study in The Netherlands: agreement between questionnaire information and medical records. Neth J Med (1999) 1.22
Can adverse drug reactions be detected earlier? A comparison of reports by patients and professionals. BMJ (1996) 1.22
Carcinosarcomas (malignant mixed mullerian tumors) of the female genital tract: comparative molecular analysis of epithelial and mesenchymal components. Hum Pathol (1998) 1.18
Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study. Osteoporos Int (2010) 1.17
Mapping of RNA transcribed from a region of the Herpesvirus saimiri genome required for oncogenicity. J Virol (1984) 1.14
T-DNA organization in homogeneous and heterogeneous octopine-type crown gall tissues of Nicotiana tabacum. Cell (1982) 1.14
NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics. Arch Intern Med (1998) 1.14
Clinical pharmacy: looking 20 years back... looking 20 years forward. Pharmacotherapy (2000) 1.13
Scenario analysis of the future of medicines. BMJ (1994) 1.11
Determination of tumor aggressiveness in colorectal cancer by K-ras-2 analysis. Arch Surg (1993) 1.10
Information on drug use in the elderly: a comparison of pharmacy, general-practitioner and patient data. Pharm World Sci (1995) 1.10
Control of blood pressure and risk of stroke among pharmacologically treated hypertensive patients. Stroke (2000) 1.10
Influence of question structure on the recall of self-reported drug use. J Clin Epidemiol (2000) 1.10
Immunogenetics of human minor histocompatibility antigens: their polymorphism and immunodominance. Immunogenetics (1992) 1.10
Use of inhaled corticosteroids and risk of fractures. J Bone Miner Res (2001) 1.10
Risk factors for the development of adverse drug events in hospitalized patients. Pharm World Sci (2000) 1.09
Current use of thiazide diuretics and prevention of femur fractures. J Clin Epidemiol (1996) 1.09
p53 sequence analysis predicts treatment response and outcome of patients with esophageal carcinoma. Cancer (1998) 1.08
Agreement between self-reported antihypertensive drug use and pharmacy records in a population-based study in The Netherlands. Pharm World Sci (1999) 1.05
Detection of infrequent and multiple K-ras mutations in human tumors and tumor-adjacent tissues. Anal Biochem (1997) 1.04
Polypyrimidine tract-binding protein and heterogeneous nuclear ribonucleoprotein A1 bind to human T-cell leukemia virus type 2 RNA regulatory elements. J Virol (1995) 1.03
Two sides of the same coin: Wnt signaling in neurodegeneration and neuro-oncology. Biosci Rep (2005) 1.03
Determinants of pharmacists' interventions linked to prescription processing. Pharm World Sci (2001) 1.03
Adverse drug events in hospitalized patients. A comparison of doctors, nurses and patients as sources of reports. Eur J Clin Pharmacol (1999) 1.02
Specific binding of polypyrimidine tract binding protein and hnRNP A1 to HIV-1 CRS elements. Virus Genes (1996) 1.02
Existence of mature human CD4+ T cells with genuine class I restriction. Eur J Immunol (1992) 1.02
Public health impact of adverse bone effects of oral corticosteroids. Br J Clin Pharmacol (2001) 1.01
Regional cerebral blood flow in humans at high altitude: gradual ascent and 2 wk at 5,050 m. J Appl Physiol (1985) (2013) 1.01
Synthesis of bovine growth hormone in primates by using a herpesvirus vector. Mol Cell Biol (1985) 1.00
A meta-analysis of the treatment of panic disorder with or without agoraphobia: a comparison of psychopharmacological, cognitive-behavioral, and combination treatments. J Nerv Ment Dis (1997) 1.00
K-ras gene mutations in normal colorectal tissues from K-ras mutation-positive colorectal cancer patients. Cancer Res (1997) 0.99
K-ras and p53 mutations in aberrant crypt foci and colonic tumors from colon cancer patients. Cancer Lett (1997) 0.98
Sporadic and Thorotrast-induced angiosarcomas of the liver manifest frequent and multiple point mutations in K-ras-2. Lab Invest (1997) 0.98
[Pharmaco-morbidity linking: a pilot study of its technical possibilities in The Netherlands]. Ned Tijdschr Geneeskd (1990) 0.97
Renal function in summer frogs and winter frogs. J Physiol (1924) 0.97
Relationship of p53 gene alterations with tumor progression and recurrence in olfactory neuroblastoma. Am J Surg Pathol (1996) 0.97
Inhibition of HIV-1 replication using a mutated tRNALys-3 primer. J Biol Chem (1997) 0.95
Multiple genetic alterations involved in the tumorigenesis of human cholangiocarcinoma: a molecular genetic and clinicopathological study. J Cancer Res Clin Oncol (2001) 0.95
Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome. Am J Pathol (1996) 0.94
Measurement of patient compliance. Pharm World Sci (1998) 0.93
Neighbourhood characteristics and use of benzodiazepines in The Netherlands. Soc Sci Med (1999) 0.93
A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder. Collaborative Paroxetine Panic Study Investigators. Acta Psychiatr Scand (1997) 0.93
Determinants of signal selection in a spontaneous reporting system for adverse drug reactions. Br J Clin Pharmacol (2001) 0.93
Differences in attitudes, knowledge and use of economic evaluations in decision-making in The Netherlands. The Dutch results from the EUROMET Project. Pharmacoeconomics (2000) 0.92
Luminal foam cell accumulation is associated with smooth muscle cell death in the intimal thickening of human saphenous vein grafts. Circulation (1996) 0.91
Pyrazinamide use as a method of estimating under-reporting of tuberculosis. Int J Tuberc Lung Dis (2001) 0.91
Prognostic value of TP53 and K-ras-2 mutational analysis in stage III carcinoma of the colon. Am J Surg (1996) 0.91
HLA class II+ human keratinocytes present Mycobacterium leprae antigens to CD4+ Th1-like cells. Scand J Immunol (1993) 0.90
Contact site between inner and outer mitochondrial membrane: a dynamic microcompartment for creatine kinase activity. Biochim Biophys Acta (1990) 0.90
Long-term oral contraceptive use increases breast cancer risk in women over 55 years of age: the DOM cohort. Int J Cancer (2000) 0.90
Use of nonsteroidal anti-inflammatory drugs and risk of fractures. Bone (2000) 0.89
Undertreatment of hypertension in a population-based study in The Netherlands. J Hypertens (1998) 0.89
Frequent allelic imbalance and loss of protein expression of the DNA repair gene hOGG1 in head and neck squamous cell carcinoma. Lab Invest (2001) 0.88
Incidence of antidepressant drug use in older adults and association with chronic diseases: the Rotterdam Study. Int Clin Psychopharmacol (1997) 0.87
K-ras-2 and p53 genotyping of intestinal-type adenocarcinoma of the nasal cavity and paranasal sinuses. Mod Pathol (1996) 0.87
Sex differences in antihypertensive drug use: determinants of the choice of medication for hypertension. J Hypertens (1998) 0.87
Incidence and determinants of migraine prophylactic medication in the Netherlands. Eur J Clin Pharmacol (2002) 0.86
Well-differentiated villoglandular adenocarcinoma of the uterine cervix: oncogene/tumor suppressor gene alterations and human papillomavirus genotyping. Int J Gynecol Pathol (2000) 0.86
Spontaneous lapses in dosing during chronic treatment with selective serotonin reuptake inhibitors. Br J Psychiatry (2001) 0.86
Genotypic analysis of pulmonary Langerhans cell histiocytosis. Hum Pathol (2003) 0.85
Utilization patterns of non-steroidal anti-inflammatory drugs in an open Dutch population. Pharm Weekbl Sci (1990) 0.85
The role of p53 mutation and protein expression in primary and recurrent adenoid cystic carcinoma. Hum Pathol (1996) 0.85
Reduction in the therapeutic intensity of abortive migraine drug use during ACE inhibition therapy--a pilot study. Pharmacoepidemiol Drug Saf (2004) 0.85